Medicure acquires full US ownership of Zypitamag

Medicure Inc. a cardiovascular pharmaceutical company, is pleased to a...

September 30, 2019 | Monday | News
Sobi to acquire Dova Pharma, expands Haematology platform

Swedish Orphan Biovitrum AB (SOBI) has announced a definitive agreemen...

September 30, 2019 | Monday | News
New NIH program provides treatment for inherited blood and immune diseases

People with inherited diseases of the blood and immune system can now ...

September 27, 2019 | Friday | News
Bactiguard inks global license pact with Zimmer Biomet

Stockholm headquartered Bactiguard has entered into an exclusive, glob...

September 27, 2019 | Friday | News
NIH to accelerate progress in TB vaccine development

The National Institute of Allergy and Infectious Diseases (NIAID), par...

September 27, 2019 | Friday | News
Vitrakvi receives first tumor-agnostic approval in EU

Bayer has announced that the European Commission has granted marketing...

September 25, 2019 | Wednesday | News
Bayer, BWH, MGH open joint lab for research

Bayer and Partners HealthCare’s founding members Brigham and Wom...

September 26, 2019 | Thursday | News
AbbVie to present new and updated data from 22 abstracts

AbbVie , a research-based global biopharmaceutical company, has announ...

September 24, 2019 | Tuesday | News
Merck’s PIFELTRO™ and DELSTRIGO™ get FDA permission to treat HIV-1

Merck has announced that the U.S. Food and Drug Administration (FDA) a...

September 24, 2019 | Tuesday | News
BioMed X completes research collaboration with Roche

BioMed X has announced the completion of their first research col...

September 23, 2019 | Monday | News
Countries must invest at least 1% more of GDP on primary health care to eliminate coverage gaps: WHO

Countries must increase spending on primary healthcare by at least 1% ...

September 23, 2019 | Monday | News
Boehringer Ingelheim puts focus on novel therapies for retinal diseases

German player Boehringer Ingelheim and US based Inflammasome Therapeut...

September 24, 2019 | Tuesday | News
VBI Vaccines announces pricing of $35M public offering

VBI Vaccines Inc., a US based commercial-stage biopharmaceutical compa...

September 20, 2019 | Friday | News
Inovio receives NIH funding to combat antimicrobial-resistant Infection

Inovio Pharmaceuticals has announced that the company and its collabor...

September 20, 2019 | Friday | News
FDA grants Fast Track designation for Farxiga in heart failure

AstraZeneca has announced that the US Food and Drug Administration (FD...

September 19, 2019 | Thursday | News
AstraZeneca amends collaboration with Ironwood for Linzess

AstraZeneca has amended its collaboration agreement with Iro...

September 19, 2019 | Thursday | News
EU & WHO join forces to promote benefits of vaccines

The European Commission and the World Health Organization (WHO) recent...

September 19, 2019 | Thursday | News
AskBio acquires assets from RoverMed BioSciences

Asklepios BioPharmaceutical (AskBio), a fully integrated Adeno-Associa...

September 18, 2019 | Wednesday | News

Have an Account?

OR

Forgot your password?

OR

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy